![[Article Title]](https://media.americanpharmaceuticalreview.com/m/28/article/625856-134x100.jpg)
Manufacturing extracellular vesicles at clinical scale presents significant downstream processing challenges. This application note describes how an integrated TFDF and TFF platform replaces traditional centrifugation with a fully closed, GMP-ready workflow, delivering high recovery yields and reproducible results from lab development through 200+ liter scale.